CUP AND HANDLE FORMING NEW PT 6.50+Price above 200 EMA. Bounced off-diagonal support. Bounced off 50% retracement. RSI Oversold. Confirmed trend reversal.
Next report date
≈
August 6
Report period
Q2 2025
EPS estimate
−0.63 USD
Revenue estimate
6.02 M USD
−3.19 USD
−130.64 M USD
10.00 M USD
48.71 M
About Verastem, Inc.
Sector
Industry
CEO
Daniel W. Paterson
Website
Headquarters
Needham
Founded
2010
FIGI
BBG001J2LSK5
Verastem, Inc. is a biopharmaceutical company, which engages in the development and commercialization of drugs for the treatment of cancer. The company was founded by Richard H. Aldrich, Michelle Dipp, Piyush Gupta, Satish Jindal, Eric S. Lander, Robert F. Weinberg, and Christoph H. Westphal on August 4, 2010 and is headquartered in Needham, MA.
−82.8%
−82.1%
−81.4%
−80.7%
−80.0%
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−75.00 M
−50.00 M
−25.00 M
0.00
25.00 M
Revenue
Net income
Net margin %
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
−60.00 M
−45.00 M
−30.00 M
−15.00 M
0.00
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
−60.00 M
−45.00 M
−30.00 M
−15.00 M
0.00
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
−40.00 M
0.00
40.00 M
80.00 M
120.00 M
Debt
Free cash flow
Cash & equivalents
No news here
Looks like there's nothing to report right now
FDA gave breakthrough designation..Verastem announced it received FDA Breakthrough Therapy designation for VS-6766 with defactinib in recurrent low-grade serous ovarian cancer.
If the flag holds, it looks like it could hit around $4.60. Considering adding to my position today. But probably will just hold with what I have.
$VSTM Verastem, Inc., Potential 20% UpsideVerastem, Inc., operating as Verastem Oncology, is a biopharmaceutical company focusing on developing and commercializing medicines to improve the survival and quality of life of cancer patients. It markets COPIKTRA™ (duvelisib), an oral inhibitor of phosphoinositide 3-kinase (PI3K) and dual inhibit
$VSTM Bullish opportunity targeting double current price 1.48Bullish setup formed by 3 red daily candles closing at same price . this pattern can lead to significant price change and RSI signal positively .. bullish long more likely with stoploss at 1.25 (not far away) risk reward (-20% vs +100%). to be watched closely!!
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VSTM is 7.59 USD — it has decreased by −4.29% in the past 24 hours. Watch Verastem, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Verastem, Inc. stocks are traded under the ticker VSTM.
VSTM stock has risen by 6.15% compared to the previous week, the month change is a 59.45% rise, over the last year Verastem, Inc. has showed a −42.33% decrease.
We've gathered analysts' opinions on Verastem, Inc. future price: according to them, VSTM price has a max estimate of 20.00 USD and a min estimate of 13.00 USD. Watch VSTM chart and read a more detailed Verastem, Inc. stock forecast: see what analysts think of Verastem, Inc. and suggest that you do with its stocks.
VSTM reached its all-time high on Jul 11, 2013 with the price of 225.93 USD, and its all-time low was 2.10 USD and was reached on Aug 5, 2024. View more price dynamics on VSTM chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VSTM stock is 7.01% volatile and has beta coefficient of 0.87. Track Verastem, Inc. stock price on the chart and check out the list of the most volatile stocks — is Verastem, Inc. there?
Today Verastem, Inc. has the market capitalization of 417.06 M, it has increased by 11.51% over the last week.
Yes, you can track Verastem, Inc. financials in yearly and quarterly reports right on TradingView.
Verastem, Inc. is going to release the next earnings report on Aug 6, 2025. Keep track of upcoming events with our Earnings Calendar.
VSTM earnings for the last quarter are −0.96 USD per share, whereas the estimation was −0.70 USD resulting in a −37.14% surprise. The estimated earnings for the next quarter are −0.63 USD per share. See more details about Verastem, Inc. earnings.
Verastem, Inc. revenue for the last quarter amounts to 0.00 USD, despite the estimated figure of 100.00 K USD. In the next quarter, revenue is expected to reach 6.02 M USD.
VSTM net income for the last quarter is −52.10 M USD, while the quarter before that showed −64.55 M USD of net income which accounts for 19.28% change. Track more Verastem, Inc. financial stats to get the full picture.
No, VSTM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 18, 2025, the company has 78 employees. See our rating of the largest employees — is Verastem, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Verastem, Inc. EBITDA is −131.04 M USD, and current EBITDA margin is −1.15 K%. See more stats in Verastem, Inc. financial statements.
Like other stocks, VSTM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Verastem, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Verastem, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Verastem, Inc. stock shows the buy signal. See more of Verastem, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.